11:18 AM EDT, 08/12/2025 (MT Newswires) -- Coya Therapeutics ( COYA ) filed a registration statement Tuesday for the potential sale of up to $75 million of its securities from time to time.

The filing covers common stock, preferred stock, warrants, debt securities, subscription rights and units.

The company said it will use the net proceeds for general corporate purposes, which may include financing administrative expenses, research and development, product manufacturing, preclinical studies, clinical trials, regulatory advancement of clinical candidates, acquisitions or investments, boosting working capital, lowering debt, and capital expenditures.

Shares of Coya Therapeutics ( COYA ) were up over 4% in recent trading.

Price: 6.34, Change: +0.27, Percent Change: +4.42